WEBSTER BANK, N. A. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 42 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
WEBSTER BANK, N. A. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$18,828
+0.2%
1,5270.0%0.00%
+50.0%
Q2 2023$18,782
+0.1%
1,5270.0%0.00%0.0%
Q1 2023$18,767
+110294.1%
1,5270.0%0.00%0.0%
Q4 2022$17
-99.8%
1,527
-50.0%
0.00%0.0%
Q3 2022$11,000
-38.9%
3,0550.0%0.00%0.0%
Q2 2022$18,000
-5.3%
3,0550.0%0.00%0.0%
Q1 2022$19,000
+58.3%
3,0550.0%0.00%
+100.0%
Q4 2021$12,000
-20.0%
3,0550.0%0.00%
-50.0%
Q3 2021$15,000
-25.0%
3,0550.0%0.00%0.0%
Q2 2021$20,000
+5.3%
3,0550.0%0.00%0.0%
Q1 2021$19,000
-9.5%
3,0550.0%0.00%0.0%
Q4 2020$21,000
+75.0%
3,0550.0%0.00%0.0%
Q3 2020$12,000
+20.0%
3,0550.0%0.00%
+100.0%
Q2 2020$10,000
+42.9%
3,0550.0%0.00%0.0%
Q1 2020$7,000
-30.0%
3,0550.0%0.00%0.0%
Q4 2019$10,000
-28.6%
3,0550.0%0.00%
-50.0%
Q3 2019$14,000
-22.2%
3,0550.0%0.00%0.0%
Q2 2019$18,000
-14.3%
3,0550.0%0.00%
-33.3%
Q1 2019$21,000
+75.0%
3,0550.0%0.00%
+50.0%
Q4 2018$12,000
-25.0%
3,0550.0%0.00%0.0%
Q3 2018$16,000
+6.7%
3,0550.0%0.00%0.0%
Q2 2018$15,000
-40.0%
3,0550.0%0.00%
-50.0%
Q1 2018$25,000
-19.4%
3,0550.0%0.00%0.0%
Q4 2017$31,0003,0550.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Rise Advisors, LLC 272$4,1080.00%
DIMENSIONAL FUND ADVISORS LP 318,995$4,826,3940.00%
Covestor Ltd 106$00.00%
Farther Finance Advisors, LLC 77$00.00%
JBF Capital, Inc. 39,637$1,1890.00%
GOLDMAN SACHS GROUP INC 29,807$450,9800.00%
NISA INVESTMENT ADVISORS, LLC 15$00.00%
CWM, LLC 22$00.00%
CALDWELL SUTTER CAPITAL, INC. 7,458$00.00%
RHUMBLINE ADVISERS 2,480$37,5190.00%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders